| Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study (NCT05309265) | Azienda USL Reggio Emilia - IRCCS | 2022-07-07 |
| Factor Influencing Breast Surgery Type Decision-Making (NCT05604677) | Etienne El Helou | 2022-06-15 |
| Lymphaticovenous Anastomosis as Treatment for Lymphedema (NCT05441943) | Odense University Hospital | 2022-05-11 |
| Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer (NCT05169567) | Eli Lilly and Company | 2022-03-11 |
| Project Breast47: Effect of an Educational Intervention (NCT05267171) | University of Oviedo | 2022-01-15 |
| Surgical Pre-habilitation in Breast Cancer. (NCT04861220) | Instituto Nacional de Cancer, Brazil | 2022-01-01 |
| Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO) (NCT04583124) | Universidad de Granada | 2021-09-30 |
| Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities (NCT06058650) | Mayo Clinic | 2021-08-26 |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors (NCT05364450) | Indiana University | 2021-08-17 |
| Complications After Lumpectomy, Sentinel Node and Radiotherapy in Breast Cancer Patients and Physiotherapy Care (NCT04444882) | University Hospital, Grenoble | 2021-06-01 |
| Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion Localization (NCT04893421) | Sunnybrook Health Sciences Centre | 2021-05-16 |
| Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy (NCT06212440) | National Cancer Center, Korea | 2021-05-04 |
| Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups (NCT04767464) | Mary Radomski | 2021-03-01 |
| Regional Anesthesia and Partial Mastectomy (NCT04824599) | Karlstad Central Hospital | 2021-02-19 |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929) | Carisma Therapeutics Inc | 2021-02-02 |
| Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program (NCT04652609) | Universidad de Granada | 2021-01-01 |
| Ultrasonographic Axillary Localization (NCT04644848) | Mansoura University | 2020-12-15 |
| Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors (NCT04640220) | Yeungnam University Hospital | 2020-10-26 |
| Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy (NCT05427071) | The University of Hong Kong | 2020-10-15 |
| Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors (NCT03935282) | Wake Forest University Health Sciences | 2020-10-01 |
| TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer (NCT04489173) | Borstkanker Onderzoek Groep | 2020-09-25 |
| Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment (NCT05576545) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2020-09-18 |
| Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia (NCT05050890) | Instituto Brasileiro de Controle do Cancer | 2020-08-05 |
| The Effects of Perioperative PECS Block During Robotic Breast Surgery and Breast Reconstruction (NCT04440995) | Yonsei University | 2020-07-08 |
| Real-life Pan-HER-blockade With Neratinib (NCT04388384) | Pierre Fabre Pharma GmbH | 2020-07-02 |
| Non-mass Enhancement in Breast MRI (NCT04083027) | Assiut University | 2020-03-01 |
| Circulating Tumor Cells Screen for Breast Cancer (NCT05633680) | Handan First Hospital | 2020-02-20 |
| Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring (NCT04799535) | Mayo Clinic | 2019-09-01 |
| Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome (NCT03761420) | St. Olavs Hospital | 2019-08-01 |
| Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket) (NCT03868514) | pfm medical gmbh | 2019-07-04 |
| Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer (NCT03874598) | Universität Duisburg-Essen | 2019-06-12 |
| Feasibility of Preoperative Tattooing of Percutaneously Biopsied Axillary Lymph Node: A Quasi Experimental Pilot Study (NCT03939598) | Aga Khan University | 2019-03-27 |
| Aspects of Breast-conserving Surgery (NCT04227613) | Lund University | 2019-01-01 |
| MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC (NCT03881605) | Sunnybrook Health Sciences Centre | 2018-11-08 |
| The Genetic Education for Men Trial: Web-Based Education vs. Standard Care (NCT02957981) | Georgetown University | 2018-10-01 |
| Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography (NCT03266562) | Mayo Clinic | 2018-09-01 |
| Anlotinib in Metastatic HER2 Negative Breast Cancer (NCT04002284) | Peng Yuan | 2018-07-12 |
| G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer (NCT03455270) | G1 Therapeutics, Inc. | 2018-05-09 |
| Combination Study of SV-BR-1-GM With Retifanlimab (NCT03328026) | BriaCell Therapeutics Corporation | 2018-03-16 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers (NCT03013881) | United BioPharma | 2018-03-05 |
| Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE® (NCT03445637) | Pfizer | 2018-02-08 |
| Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy (NCT03740984) | Dr. Horst Schmidt Klinik GmbH | 2018-02-01 |
| A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer (NCT03275727) | Linkoeping University | 2018-02-01 |
| Testing of the Cancer Thriving and Surviving Breast Cancer Program (NCT03651921) | Manuela Eicher | 2017-12-12 |
| Effectiveness of a Modern Educational Intervention in Breast Cancer Patients (NCT03351075) | Universitaire Ziekenhuizen KU Leuven | 2017-11-27 |
| Giving Information on the Risks and Limitations of Mammography Screening (GIRLS) (NCT02914197) | McMaster University | 2017-11-20 |
| Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic Surgery (NCT03330717) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2017-11-15 |
| EPR Tumor Oximetry With CE India Ink (NCT03321903) | Philip Schaner | 2017-08-30 |
| Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy (NCT03280836) | Milton S. Hershey Medical Center | 2017-08-03 |
| Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery (NCT03202472) | Jonsson Comprehensive Cancer Center | 2017-08-03 |
| The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer Patients (NCT03024463) | Shandong Cancer Hospital and Institute | 2017-08-01 |
| Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy (NCT03220178) | Palleos Healthcare GmbH | 2017-07-24 |
| Decongestive Exercise and Compression for Breast Cancer Related Lymphedema Management (NCT02992782) | University of Alberta | 2017-06-01 |
| SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer (NCT03066947) | BriaCell Therapeutics Corporation | 2017-05-05 |
| Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer (NCT03141437) | M.D. Anderson Cancer Center | 2017-04-23 |
| Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer (NCT03269981) | Samsung Medical Center | 2017-04-01 |
| RISAS Procedure in Node Positive Breast Cancer Following NAC (NCT02800317) | Erasmus Medical Center | 2017-03-30 |
| A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer (NCT03024580) | Instituto Nacional de Cancer, Brazil | 2017-03-06 |
| Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) (NCT02950259) | Providence Health & Services | 2017-02-09 |
| Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) (NCT02978716) | G1 Therapeutics, Inc. | 2017-02-02 |
| Presentation of First Time Attenders at Lymphedema Clinics (NCT03687749) | Universitaire Ziekenhuizen KU Leuven | 2017-02-01 |
| G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (NCT02983071) | G1 Therapeutics, Inc. | 2017-01-01 |
| Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM) (NCT03008031) | Maastricht University Medical Center | 2017-01-01 |
| SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer (NCT02970682) | Evgen Pharma | 2016-10-01 |
| Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy. (NCT03273426) | Seoul National University Hospital | 2016-09-08 |
| Combined Training Intervention for Women Who Underwent Primary Treatment for Breast Cancer (NCT03124095) | Federal University of Pelotas | 2016-09-01 |
| Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction (NCT02913573) | Huntington Memorial Hospital | 2016-09-01 |
| HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life (NCT03000192) | University Hospital Southampton NHS Foundation Trust | 2016-08-01 |
| Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery (NCT02372305) | University of Arkansas | 2016-03-01 |
| Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer (NCT02455141) | Shanghai Jiao Tong University School of Medicine | 2016-03-01 |
| Breast Edema Compression Vest (NCT02627976) | UMC Utrecht | 2016-02-01 |
| Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRL (NCT02609724) | Universitaire Ziekenhuizen KU Leuven | 2016-01-01 |
| Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema Prevention (NCT02318615) | Peking University People's Hospital | 2015-12-01 |
| Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection (NCT02610920) | Columbia University | 2015-12-01 |
| Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. (NCT03606369) | Instituto Nacional de Cancerologia de Mexico | 2015-11-05 |
| [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer (NCT02608216) | University of Pennsylvania | 2015-11-01 |
| 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients (NCT02602067) | sigma-tau i.f.r. S.p.A. | 2015-11-01 |
| [18F]FES PET/CT in Endocrine Refractory Breast Cancer (NCT02409316) | University of Pennsylvania | 2015-10-15 |
| Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) (NCT02513472) | Eisai Inc. | 2015-08-28 |
| Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing Lumpectomy (NCT02432118) | Stanford University | 2015-05-01 |
| The Preemptive Analgesic Efficacy of Nefopam (NCT02561468) | Seoul National University Bundang Hospital | 2015-04-01 |
| [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer (NCT02284919) | University of Pennsylvania | 2015-03-11 |
| SAVI SCOUT Clinical Evaluation Study (NCT02370082) | Cianna Medical, Inc. | 2015-02-01 |
| Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer (NCT02316561) | UMC Utrecht | 2014-10-01 |
| Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast Cancer (NCT01755130) | M.D. Anderson Cancer Center | 2014-05-13 |
| Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer (NCT02065960) | Juravinski Cancer Center | 2014-02-01 |
| Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment (NCT02061085) | MedSIR | 2013-07-01 |
| Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer (NCT01766297) | Proton Collaborative Group | 2013-02-01 |
| Proton Radiation for Stage II/III Breast Cancer (NCT01758445) | Proton Collaborative Group | 2013-02-01 |
| Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib (NCT02056080) | MedSIR | 2013-01-01 |
| The Impact of Physical Activity on the Outcome of Surgery (NCT01707121) | Sahlgrenska University Hospital | 2012-12-01 |
| Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment (NCT01596530) | AstraZeneca | 2012-06-01 |
| Assessing the Patient Experience in Cancer Care (NCT01621295) | Mayo Clinic | 2012-05-01 |
| Study of AFP464 +/- Faslodex in ER + Breast Cancer (NCT01233947) | Tigris Pharmaceuticals | 2011-05-01 |
| Tesetaxel as First-line Therapy for Metastatic Breast Cancer (NCT01221870) | Genta Incorporated | 2010-11-01 |
| Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer (NCT01199393) | Peking University Cancer Hospital & Institute | 2010-08-01 |
| Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer (NCT01015521) | Tigris Pharmaceuticals | 2010-04-01 |
| A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer (NCT00771381) | AHS Cancer Control Alberta | 2008-11-28 |
| Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2) (NCT00638963) | Merck Sharp & Dohme LLC | 2008-10-02 |
| Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment (NCT01859936) | Karolinska University Hospital | 2008-02-01 |